Page last updated: 2024-10-30

mebendazole and Stevens-Johnson Syndrome

mebendazole has been researched along with Stevens-Johnson Syndrome in 2 studies

Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.

Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, KT1
Twu, SJ1
Chang, HJ1
Lin, RS1
Ajonuma, LC1
Chika, LC1

Other Studies

2 other studies available for mebendazole and Stevens-Johnson Syndrome

ArticleYear
Outbreak of Stevens-Johnson syndrome/toxic epidermal necrolysis associated with mebendazole and metronidazole use among Filipino laborers in Taiwan.
    American journal of public health, 2003, Volume: 93, Issue:3

    Topics: Adult; Antinematodal Agents; Antitrichomonal Agents; Disease Outbreaks; Female; Humans; Male; Mebend

2003
Outbreak of Stevens-Johnson syndrome among Filipino overseas contract workers using mebendazole for helminthiasis prophylaxis.
    Tropical doctor, 2000, Volume: 30, Issue:1

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Antinematodal Agents; Cluster Analysis; Disease Outb

2000